BioHarvest Sciences Common Stock Net 2020-2024 | BHST
BioHarvest Sciences common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.
BioHarvest Sciences Annual Common Stock Net
(Millions of US $) |
| 2023 |
$69 |
| 2022 |
$65 |
| 2021 |
$63 |
| 2020 |
$48 |
| 2019 |
$16 |
| 2019 |
$9 |
| 2018 |
$ |
BioHarvest Sciences Quarterly Common Stock Net
(Millions of US $) |
| 2024-06-30 |
$97 |
| 2024-03-31 |
$87 |
| 2023-12-31 |
$69 |
| 2023-09-30 |
$69 |
| 2023-06-30 |
$68 |
| 2023-03-31 |
$67 |
| 2022-12-31 |
$65 |
| 2022-09-30 |
$65 |
| 2022-06-30 |
$64 |
| 2022-03-31 |
$63 |
| 2021-12-31 |
$63 |
| 2021-09-30 |
$62 |
| 2021-06-30 |
$55 |
| 2021-03-31 |
$54 |
| 2020-12-31 |
$48 |
| 2020-09-30 |
$47 |
| 2020-06-30 |
$43 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
|
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$9 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
